Pivotal Study to Assess Safety and Performance of Neola®, a Novel Lung Monitoring Device for Neonates

NANot yet recruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 31, 2026

Primary Completion Date

December 31, 2026

Study Completion Date

February 28, 2027

Conditions
RDS of PrematurityPreterm BirthLung Diseases
Interventions
DEVICE

Lung monitoring with the Neola device

Lung monitoring with the Neola device

Trial Locations (2)

94304

Stanford Lucile Packard Children's Hospital Neonatal Intensive Care Unit, Palo Alto

08103

Cooper Health System, Camden

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Neola Medical Inc

INDUSTRY